CANNTAB THERAPEUTICS LIMITEDCANNTAB THERAPEUTICS LIMITEDCANNTAB THERAPEUTICS LIMITED

CANNTAB THERAPEUTICS LIMITED

No trades
See on Supercharts

PILL fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Canntab Therapeutics Ltd. is a biopharmaceutical company. It engages in the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The firm's products include nanoemulsion technology, multi-particulate drug delivery systems, specialty gel capsules, propriety granulation technology, oral quick dissolve tablet, instant release solid oral, extended release solid oral, and bi-layer solid oral. The company was founded by Richard Goldstein and Jeffrey W. Renwick on May 31, 2010 and is headquartered in Markham, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

PILL does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company